Perrigo Company PLC
NYSE:PRGO
Intrinsic Value
Perrigo Co. Plc engages in the provision of self-care products and over-the-counter (OTC) health and wellness solutions. [ Read More ]
The intrinsic value of one PRGO stock under the Base Case scenario is 67.74 USD. Compared to the current market price of 30.06 USD, Perrigo Company PLC is Undervalued by 56%.
Valuation Backtest
Perrigo Company PLC
Run backtest to discover the historical profit from buying and selling PRGO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Perrigo Company PLC
Current Assets | 2.8B |
Cash & Short-Term Investments | 751.4m |
Receivables | 768.1m |
Other Current Assets | 1.3B |
Non-Current Assets | 8B |
Long-Term Investments | 60.1m |
PP&E | 1.1B |
Intangibles | 6.5B |
Other Non-Current Assets | 287.2m |
Current Liabilities | 1.6B |
Accounts Payable | 477.7m |
Accrued Liabilities | 625.9m |
Other Current Liabilities | 482.7m |
Non-Current Liabilities | 4.5B |
Long-Term Debt | 3.6B |
Other Non-Current Liabilities | 822.1m |
Earnings Waterfall
Perrigo Company PLC
Revenue
|
4.7B
USD
|
Cost of Revenue
|
-3B
USD
|
Gross Profit
|
1.7B
USD
|
Operating Expenses
|
-1.4B
USD
|
Operating Income
|
284.1m
USD
|
Other Expenses
|
-296.8m
USD
|
Net Income
|
-12.7m
USD
|
Free Cash Flow Analysis
Perrigo Company PLC
What is Free Cash Flow?
PRGO Profitability Score
Profitability Due Diligence
Perrigo Company PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Perrigo Company PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
PRGO Solvency Score
Solvency Due Diligence
Perrigo Company PLC's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
Perrigo Company PLC's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PRGO Price Targets Summary
Perrigo Company PLC
According to Wall Street analysts, the average 1-year price target for PRGO is 41.31 USD with a low forecast of 39.39 USD and a high forecast of 44.1 USD.
Ownership
PRGO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
PRGO Price
Perrigo Company PLC
Average Annual Return | -6.06% |
Standard Deviation of Annual Returns | 7.46% |
Max Drawdown | -54% |
Market Capitalization | 4.1B USD |
Shares Outstanding | 135 520 000 |
Percentage of Shares Shorted | 3.21% |
PRGO News
Last Important Events
Perrigo Company PLC
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Perrigo Company PLC
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Perrigo Co. Plc engages in the provision of self-care products and over-the-counter (OTC) health and wellness solutions. The company is headquartered in Dublin, Dublin and currently employs 9,900 full-time employees. The firm operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S) and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies, and e-commerce channels.
Contact
IPO
Employees
Officers
The intrinsic value of one PRGO stock under the Base Case scenario is 67.74 USD.
Compared to the current market price of 30.06 USD, Perrigo Company PLC is Undervalued by 56%.